The data show that RRBP1 is an independent prognostic factor for both OS (Table 3, confidence interval [CI] = 1.346−4.102, P=0.003) and DFS (Table 3, CI = 1.554−3.709, P<0.001) in patients with epithelial ovarian cancer. Here, RRBP1 is linked to ovarian carcinoma.